New Medicine Recommendation 5% imiquimod cream (Aldara) and
Details of Review. Name of medicine (generic & brand name): imiquimod 5% cream (Aldara®) and fluorouracil. 5% cream (Efudix®). Strengths and forms:.
imiquimod fu creams new medicine review
N20-723S020 Imiquimod Clinical BPCA
13 déc. 2006 Clinical Review. Elektra J. Papadopoulos. NDA 20723. Aldara Imiquimod 5% Cream. Table of Contents. 1 EXECUTIVE SUMMARY .
N S Imiquimod Clinical BPCA
Imiquimod Cream 5%
1 déc. 2012 drug (RLD) Aldara Cream
Orig s
201153 Imiquimod Clinical PREA
7 juin 2010 4 SIGNIFICANT EFFICACY/SAFETY ISSUES RELATED TO OTHER REVIEW ... Imiquimod 5% cream (Aldara) has been marketed for over 8 years for the.
Imiquimod Clinical PREA
APPLICATION NUMBER: - 2011153Orig1s000 OTHER REVIEW(S)
24 mars 2011 This SEALD Labeling Review identifies major aspects of the draft ... recommendations for Aldara (imiquimod) cream PPI review provided to ...
Orig s OtherR
201153Orig1s000
25 mars 2010 PHARMACOLOGY/TOXICOLOGY NDA REVIEW AND EVALUATION ... 13) NDA 20-723 [Aldara (imiquimod) 5% cream; external genital/perianal warts;.
Orig s PharmR
ALDARA™ [al dar' a] (imiquimod) Cream 5% For Dermatologic Use
Imiquimod has no direct antiviral activity in cell culture. A study in 22 patients with genital/perianal warts comparing Aldara Cream and vehicle shows that
s lbl
22483Orig1s000
12 juin 2009 and Aldara) for Imiquimod cream presents a safety risk associated with ... 2009 for the proprietary name review of proposed name
Orig s NameR
A Review of Topical Imiquimod in the Management of Basal Cell
A Review of Topical Imiquimod in the Management of Basal Keywords: imiquimod aldara
Review Imiquimod and resiquimod as novel immunomodulators
Imiquimod is administered as a 5% cream (Aldara) and has been licensed for the treatment of anogenital warts in immunocompetent patients. Complete clearance of